CME Group Inc.
NASDAQ:CMEFinancial - Data & Stock Exchanges
-$6.03 today
- Market cap
- $111.05B
- Beta
- 0.24
- P/E (TTM)
- 20.9
- EPS (TTM)
- $11.81
- Dividend yield
- 4.56%
Volume 2.01M
Average 2.82M
CME Goodwill
The premium paid for acquisitions above the fair value of the identifiable net assets acquired.
CME Group Inc.NASDAQ: CME
Goodwill · Q3 FY2026 · quarter ended Sep 2026
Goodwill broadly unchanged from a year ago
Goodwill stood at $10.51B at the end of Q3 FY2026, down 0.1% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +0.1% a year.
Context
- Goodwill amounted to 5.5% of total assets at the end of Q3 FY2026, down 0.1 pp from a year earlier.
- Goodwill increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether goodwill keeps falling in the next quarterly balance sheet after a -0.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Goodwill history
USD · from the balance sheet
- Latest · FY2025
- 10.51B USD
- Year-over-year change
- +0.3%
- 4-year CAGR
- -0.0%
| Period | Period end | Goodwill | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.51B | +0.3% |
| FY2024 | 2024-12-31 | 10.49B | -0.1% |
| FY2023 | 2023-12-31 | 10.5B | +0.1% |
| FY2022 | 2022-12-31 | 10.48B | -0.4% |
| FY2021 | 2021-12-31 | 10.53B | — |
Goodwill vs competitors
How CME compares with its peers on the latest reported figures
- CME's Sep 2026 goodwill of $10.51B is the 3rd highest of the 4 companies compared; the peer median is $14.25B.
- Its year-over-year change of -0.1% is the 3rd highest of 4, against a peer median of -0.1%.
- Goodwill amounts to 5.5% of total assets for CME, versus a peer median of 38.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $30.63B | -0.1% | +13.2% | 17.6% | |
| Sep 2026 | $14.25B | -0.6% | +21.1% | 52.0% | |
| Sep 2026 | $10.51B | -0.1% | +0.1% | 5.5% | |
| Jun 2026 | $3.15B | +0.0% | +4.3% | 38.2% | |
| Peer median (excluding CME) | $14.25B | -0.1% | +13.2% | 38.2% | |
Competitors are the stored peer set for CME. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.83B | 2.72B | 2.91B | 2.89B | 4.42B |
| Short-term Investments | 115M | 96M | 111.7M | 113.2M | 125M |
| Net Receivables | 434.5M | 483.2M | 535.6M | 573.1M | 639.2M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 158.38B | 135.78B | 91.33B | 99.45B | 160.18B |
| Total Current Assets | 161.76B | 139.08B | 94.89B | 103.03B | 165.36B |
| Property, Plant & Equipment (Net) | 505.3M | 455.5M | 409.5M | 386.2M | 362.7M |
| Goodwill | 10.53B | 10.48B | 10.5B | 10.49B | 10.51B |
| Intangible Assets | 20.71B | 20.45B | 20.23B | 20B | 19.79B |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 3.28B | 3.71B | 3.69B | 3.54B | 2.4B |
| Total Non-current Assets | 35.02B | 35.1B | 34.82B | 34.41B | 33.06B |
| Total Assets | 196.78B | 174.18B | 129.71B | 137.45B | 198.42B |
| Account Payables | 48.8M | 121.4M | 90.6M | 79.9M | 71.8M |
| Short-term Debt | 749.4M | 16M | 0 | 749.8M | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 159.6B | 137.55B | 93.33B | 101.48B | 160.22B |
| Total Current Liabilities | 160.4B | 137.69B | 93.42B | 102.31B | 160.3B |
| Long-term Debt | 2.7B | 3.42B | 3.43B | 2.68B | 3.42B |
| Deferred Tax Liabilities | 5.39B | 5.36B | 5.33B | 5.25B | 5.24B |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 896.5M | 826M | 798.2M | 721.2M | 734.8M |
| Total Non-current Liabilities | 8.98B | 9.61B | 9.55B | 8.65B | 9.4B |
| Total Liabilities | 169.38B | 147.3B | 102.97B | 110.96B | 169.7B |
| Common Stock | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M |
| Retained Earnings | 5.15B | 4.75B | 4.46B | 4.19B | 6.43B |
| Accumulated OCI | 53.5M | (133.3M) | (55.6M) | (105.5M) | 81.9M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 27.4B | 26.88B | 26.74B | 26.49B | 28.73B |
| Total Debt | 3.45B | 3.44B | 3.43B | 3.43B | 3.42B |
| Net Debt | 610.2M | 718.3M | 513.4M | 535.6M | (994.6M) |
CME Group Inc.
NASDAQ:CME
Intrinsic Alpha fair value
Locked
Current Price
$310.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.